JNJ
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 42 on the 2026 Fortune 500 list of the largest United States corporations. In 2026, the company was ranked 43rd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Recent news mentioning JNJ
- — Why Is JNJ Stock Beating Rivals That Grow Faster?
- — Should You Judge JNJ Stock Without STELARA?
- — Monthly Paydays vs. Compound Growth: Why JNJ Beats O for Long-Term Retirees
- — NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
- — NANOBIOTIX annonce les résultats complets de la phase 1 pour JNJ-1900 (NBTXR3) dans le cancer du poumon non à petites cellules inopérable et récurrent
- — Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
- — Cramer Says It’s Time To Buy The Dip on JNJ
- — Three Dividend Kings That Pay a 75-Year-Old $3,900 a Month: KO, JNJ, and PEP
- — How a 79-Year-Old Widow Built a $6,100 Monthly Paycheck Around O, JNJ, and PFF
- — Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector?
- — Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb
- — Did A Product Swap Fuel JNJ Stock’s 54% Surge?